110816-78-9Relevant articles and documents
Pro-drugs for the oral delivery of disodium cromoglycate
Mori,Nishimura,Tamaki,Nakamura,Tsuda,Kakeya
, p. 338 - 344 (1988)
-
Antirheumatic agent
-
, (2008/06/13)
PCT No. PCT/JP97/01974 Sec. 371 Date Dec. 10, 1998 Sec. 102(e) Date Dec. 10, 1998 PCT Filed Jun. 6, 1997 PCT Pub. No. WO97/47297 PCT Pub. Date Dec. 18, 1997An antirheumatic agent comprising diethyl L-lysylcromoglycate of the following formula or a nontoxic salt thereof as an active ingredient. This compound has an anti-inflammatory action and immunomodulating action, is absorbed by oral administration to be delivered efficiently to local sites, and is associated with fewer side effects, so that it serves well as an antirheumatic agent that can be administered orally.